This study revealed the gastric cancer-associated lncRNA RNU12 is a tumor-suppressor lncRNA that inhibits cancer progression via miR-575/BLID axis, which plays crucial role in gastric cancer progression and suggest that RNU12 is potential GC marker and target for GC therapy. Here, RNU1-2 is linked to cancer.